BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giustozzi M, Franco L, Vedovati MC, Becattini C, Agnelli G. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism. J Thromb Thrombolysis 2019;48:439-53. [DOI: 10.1007/s11239-019-01878-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Araújo CDCB, Simon A, Honório TDS, da Silva SVC, Valle IMM, da Silva LCRP, Rodrigues CR, de Sousa VP, Cabral LM, Sathler PC, do Carmo FA. Development of rivaroxaban microemulsion-based hydrogel for transdermal treatment and prevention of venous thromboembolism. Colloids Surf B Biointerfaces 2021;206:111978. [PMID: 34293580 DOI: 10.1016/j.colsurfb.2021.111978] [Reference Citation Analysis]
2 Karaoui LR, Ramia E, Mansour H, Haddad N, Chamoun N. Impact of pharmacist-conducted anticoagulation patient education and telephone follow-up on transitions of care: a randomized controlled trial. BMC Health Serv Res 2021;21:151. [PMID: 33593336 DOI: 10.1186/s12913-021-06156-2] [Reference Citation Analysis]
3 Nair S, Garza N, George M, Kaatz S. Treatment of Acute Venous Thromboembolism. Med Clin North Am 2020;104:631-46. [PMID: 32505257 DOI: 10.1016/j.mcna.2020.03.004] [Reference Citation Analysis]
4 Fredenburgh JC, Weitz JI. New anticoagulants: Moving beyond the direct oral anticoagulants. J Thromb Haemost 2021;19:20-9. [PMID: 33047462 DOI: 10.1111/jth.15126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
5 Boriani G, Lee G, Parrini I, Lopez-Fernandez T, Lyon AR, Suter T, Van der Meer P, Cardinale D, Lancellotti P, Zamorano JL, Bax JJ, Asteggiano R; Council of Cardio-Oncology of the European Society of Cardiology. Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management. Eur J Prev Cardiol 2021;28:611-21. [PMID: 33624005 DOI: 10.1093/eurjpc/zwaa054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Yan T, He W, Hang C, Qin L, Qian L, Jia Z, Shi Y, Xu Y. Nurses' knowledge, attitudes, and behaviors toward venous thromboembolism prophylaxis: How to do better. Vascular 2021;29:78-84. [PMID: 32576119 DOI: 10.1177/1708538120933782] [Reference Citation Analysis]
7 Moreno-Drada JA, Abreu LG, Lino PA, Parreiras Martins MA, Pordeus IA, Nogueira Guimarães de Abreu MH. Effectiveness of local hemostatic to prevent bleeding in dental patients on anticoagulation: A systematic review and network meta-analysis. J Craniomaxillofac Surg 2021;49:570-83. [PMID: 33994071 DOI: 10.1016/j.jcms.2021.04.014] [Reference Citation Analysis]
8 Nalevaiko JZ, Marques JVO, Oliveira MF, Raetsch AWP, Marques GL, Petterle RR, Moreira CA, Borba VZC. Bone density and quality in patients treated with direct-acting oral anticoagulants versus warfarin. Bone 2021;150:116000. [PMID: 33971316 DOI: 10.1016/j.bone.2021.116000] [Reference Citation Analysis]
9 Singh B, Pai P, Kumar H, George S, Mahapatra S, Garg V, Gupta GN, Makineni K, Ganeshwala G, Narkhede P, Naqvi SMH, Gaurav K, Hukkeri MYK. Expert Recommendations on the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) from India: Current Perspective and Future Direction. Cardiol Ther 2022. [PMID: 35137335 DOI: 10.1007/s40119-022-00254-w] [Reference Citation Analysis]
10 Herrera ND, Birschmann I, Wolny M, Papich MG, Brooks MB, Goggs R. Pharmacokinetics and Biologic Activity of Apixaban in Healthy Dogs. Front Vet Sci 2021;8:702821. [PMID: 34291105 DOI: 10.3389/fvets.2021.702821] [Reference Citation Analysis]